In today’s clinical trial landscape, where complexity is the new challenge, integration is not optional: QMS defines quality, and eTMF proves it.
- The Risks Of AI In Clinical Research From A Trial Management Perspective
- How AI Models Can Actually Improve eTMF Management
- eClinical Solutions Market To Double In 5 Years, As Sponsors Prioritize Efficiency
- Is Double Programming Really Required For Validation?
- Why Is Trust Stifling Our RBM Implementations?
- Pros & Cons Of Using Wearables In Clinical Trials
- Wearables: An Essential For Decentralized Clinical Trials
- Bring-Your-Own-Device For eCOA — Is It Worth It?
ON-DEMAND WEBINARS
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
Digital health technologies can unlock meaningful insights. Explore the synergy between this cutting-edge technology and managing heart failure, and how it's paving the way for better patient care.
In this session of Digital Health Monthly, Dr. Glenn Gaesser shares his extensive research on the intersection of obesity and exercise physiology, emphasizing the importance of physical activity.
This presentation delves into pragmatic approaches for clinical evidence generation and regulatory acceptance. It examines recent FDA draft guidance on integrating RWD/RWE in medical device studies.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1401699330-microscope-lab-research-computer]( "Driving Fundamentals: Ensuring An Efficient Clinical Research Process")
Driving Fundamentals: Ensuring An Efficient Clinical Research ProcessGain insight into drawing constant parallels to clinical research teams and how easy it is for anyone executing the same processes every day to take the fundamentals for granted.
-
![eCOA Resources Overview]( "C3 Summit Recap: Shaping The Future Of eCOA/ePRO Highlights")
C3 Summit Recap: Shaping The Future Of eCOA/ePRO HighlightsUnderstand how the rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local regulations.
-
![GettyImages-1447084050 data]( "Gradually Investing In Direct Data Capture Is Inevitable")
Gradually Investing In Direct Data Capture Is InevitableGiven study decentralization and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”
-
![GettyImages-1321462048 AI, research]( "The Importance Of Clinical Research-Focused AI In Data Management")
The Importance Of Clinical Research-Focused AI In Data ManagementEveryone in clinical research is eager to accelerate progress. Learn how to unlock insights from your data swiftly to accelerate the delivery of safe new therapies.
-
![getty-1311598658-data-analytics]( "A Data-Driven Approach To Clinical Trial Site Selection")
A Data-Driven Approach To Clinical Trial Site SelectionBy incorporating data-driven site selection and verification, sponsors can optimize resource allocation, enhance protocol compliance, and improve overall trial integrity.
-
![GettyImages-1312761837 data capture]( "How Electronic Source Data Revolutionizes Clinical Research")
How Electronic Source Data Revolutionizes Clinical ResearchBy increasing interoperability and embracing digital solutions, see how the research community can maximize the benefits offered by eSource, leading to improved trial outcomes and data quality.
-
![GettyImages-1408596915 eTMF]( "Achieving Faster, Simpler Validation Through Crowdsource UAT")
Achieving Faster, Simpler Validation Through Crowdsource UATAn approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.
-
![Unlock Historical Data To Enrich RBM Insights]( "Unlock Historical Data To Enrich RBM Insights")
Unlock Historical Data To Enrich RBM InsightsThe data landscape for clinical operations is complex and comprised of many disparate sources, so a data agnostic solution is essential for full access and visibility into the data. Without an intuitive visual analytics tool, it becomes impossible to navigate data hierarchies and gain meaningful insights into the data.
-
![domino effect and risk management concept iStock-1272805554]( "eCOA Risk Management In The Digital Age")
eCOA Risk Management In The Digital AgeRegulators across the globe are urging the industry to strengthen their data integrity practices. This article addresses the additional considerations that go hand in hand with the increased reliance on eSource data and the expansion of the electronic systems in clinical trials.
-
eCOA/ePRO: Why Patients Deserve Even More Progress
The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.
